Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 2/20 | 0.52 |
| ▸ | CTSK | P43235 | 11/20 | 0.51 |
| ▸ | CTSL | P07711 | 6/20 | 0.51 |
| ▸ | CTSS | P25774 | 4/20 | 0.51 |
| ▸ | CTSB | P07858 | 2/20 | 0.48 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.47 |
| ▸ | MME | P08473 | 1/20 | 0.47 |
| ▸ | ECE1 | P42892 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL7425286 | 0.99 | CAPN1 (0.51) | CAPN1CTSKCTSLCTSSCTSB | |
| Ammonia Solution, Strong SCHEMBL7302333 | 0.90 | MME (0.43) | CTSKCTSLCTSSCTSBMME | |
| SCHEMBL9777176 | 0.89 | CAPN1 (0.54) | CAPN1CTSKCTSLCTSSCTSB | |
| SCHEMBL17693623 | 0.85 | KYNU (0.53) | CTSKCTSLCTSSCTSB | |
| Ammonia Solution, Strong SCHEMBL7300872 | 0.84 | HSD17B10 (0.44) | CTSKCTSLCTSSCTSB | |
| SCHEMBL7405358 | 0.84 | CAPN1 (0.70) | CAPN1CTSKCTSLCTSSCTSB | |
| SCHEMBL7296829 | 0.82 | GRB2 (0.47) | — | |
| SCHEMBL7294519 | 0.81 | GRB2 (0.46) | — | |
| SCHEMBL27406798 | 0.80 | CAPN1 (0.58) | CAPN1CTSKCTSLCTSSCTSB | |
| SCHEMBL27406872 | 0.79 | TYR (0.55) | CTSKCTSLCTSSCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5073547-A | DOPAMINE PRO-DRUG | SIMES SOCIETA ITALIANA MEDICINALI E SINTETICI S.P.A. (IT) | 1991-12-17 | — | — | US | disclosed |